Simpson Reps Daiichi Sankyo In $805M Plexxikon Buy
By Pete Brush · March 1, 2011, 4:05 PM EST
Daiichi Sankyo Co. Ltd. said Tuesday it will pay $805 million to buy Plexxikon Inc., a privately held pharmaceutical company based in Berkeley, Calif., with a promising late-stage treatment for metastatic...
To view the full article, register now.